Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
So nothing to really to take from it NST, I suggest you go listen to it again , instead of trying to be one of the first to post and make a fool of yourself again, if you can’t read between the lines you really are a thicko , GL
NST - Agreed, pretty much stuck to script but the one bit that he gave a little more light on was timescales for Immutex. Previously months not years, now i think he said 4 months (3 - 4 or 4 - 5 - my internet cut out).
That's me done, hold for that period at least and let the other news flow, if they are signing up 3 challenge studies this month they will definitely be RNS as new line of business.
Nothing not to like.
Just finished the webinar. wasn't much to take from it really. Similar to the one last week. Possibly a second machine, possibly another fund raise, possibly signing contracts with the big pharmas very shortly.
hVIVO COVID Clear Test "Transformational news" CF lots of news items due in the coming days.
Plus 5 x revenues streams to the business.
Very excited about the company prospects going forward.
Tiptree- Only 3 companies can offer this, Roche , Abbott and ourselves.
CE marked (certified to meet EU requirements) as of 01 May 2020 based on testing that demonstrated 100% sensitivity (ability to detect COVID-19 antibodies) and 99.8% specificity (ability to rule out the presence of COVID-19 antibodies)
Sadly, not for individuals. It seems to claim 100% accuracy: can that be right for an antibody test?
Can you put what the Webinar says afterwards? As I can't get onto it. Thank you
I dare say this is very good news but not at your suggested price point!!
Excellent - know wonder there was a big buyer earlier, 1M tests a year at £120 - £150 per = great revenue stream
Happy days. Looking forward to the webinar this evening. CF is a likeable chap so the media launch tomorrow should go brilliantly. GLALTH
Marketing - very useful. Tomorrow it begins!
Having recently secured the rights from Quotient antibody testing which detects with 100% accuracy antibodies when present (unlike finger prick tests that were recently condemned by the MHRA), hVIVO is now formally offering antibody testing to customers on Thursday 4 June 2020.
This is the first time that such on demand testing is made available to large employer groups in the UK and hVIVO’s equipment has the capability to run 3,000 samples per day, 21,000 per week, 1 million per year.
We are also seeking channel partners in the UK from GP practices, nursing services, and health clinics for phlebotomy services.
Marketing begins!
https://www.openorphan.com/covid-clear